25.39
-0.90%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Qingdao Baheal Medical
Its shares trade on Shenzhen under the ticker 301015.SZ. It has been listed since 30 June 2021. In the fiscal year to 31 December 2025, it reported revenue of CN¥7.51bn and net income of CN¥474.7m. At that date it held total assets of CN¥8.11bn and shareholders' equity of CN¥2.46bn.
Qingdao Baheal Medical, Inc. engages in the provision of marketing services for pharmaceutical product manufacturers. The company is headquartered in Qingdao, Shandong. The company went IPO on 2021-06-30. The firm provides brand operation, wholesale distribution and retail services for pharmaceutical products. Its brand operation services include consumer education, product academic promotion, marketing planning, business contacts, product distribution, flow tracking and supply chain management services. The firm's wholesale distribution business mainly centers on Qingdao and Beijing, and radiates second-level and above hospitals, community clinics and pharmacies in surrounding cities. Its wholesale distribution products include medicines, Chinese herbal medicine pieces, medical equipment, diagnostic reagents, medical consumables, among others. The firm mainly conducts its business within domestic market.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 30 Jun 2021
- Employees
- 2,642
- Website
- baheal.cn ↗
Leadership
Pay as last reported
- Mr. Gang FuChairman of the Board, General Manager, since 2024
- Mr. Zhen LiChief Financial Officer, Deputy General Manager, Secretary of the Board, Director, since 2024
- Ms. Yuan ZhangDeputy General Manager, Staff Elected Director, since 2017
- Mr. Xiaowei ZhuDeputy General Manager, Director, since 2022
- Ms. Biquan WangDeputy General Manager
- Mr. Tingwei WangDeputy General Manager
- Mr. Haishen ChenDirector
- Ms. Qing SongDirector
- Mr. Xianjing HaoIndependent Director
- Mr. Kwok Wai HoIndependent Director
- Ms. Yindi LuIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Qingdao Baheal Medical employs 2,642 full-time employees for pharmaceutical marketing services.
- The company provides brand operation services including product academic promotion and supply chain management.
- Wholesale distribution centers on Qingdao and Beijing serving hospitals and pharmacies nationwide.
Weaknesses
- The firm's business is limited to domestic market with no international expansion mentioned.
- Qingdao Baheal Medical has no mention of international market presence or global operations.
- The company focuses solely on pharmaceutical products without diversification into other health care segments.
Opportunities
- Expanding wholesale distribution to second-level cities from Qingdao and Beijing hubs.
- Increasing brand operation services for pharmaceutical manufacturers in domestic market.
- Growing demand for medical equipment and diagnostic reagents in Chinese healthcare sector.
Threats
- No mention of competitors in the pharmaceutical marketing services sector.
- The company has no data on regulatory changes affecting pharmaceutical distribution in China.
- Domestic market reliance poses risk if Chinese healthcare policies shift significantly.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.